VRAX fundamentals
An in-depth look to Virax Biolabs Group Limited operating, investing, and financing activities
VRAX free cash flow for H2 23 is -3.25 M USD. For 2023, VRAX free cash flow was -7.2 M USD and operating cash flow was -6.25 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM